rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2007-12-18
|
pubmed:abstractText |
To evaluate the clinical characteristics, treatment and outcomes of patients with osteoarticular infections (OAIs) associated with Staphylococcus aureus bacteraemia (SAB).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1460-2091
|
pubmed:author |
pubmed-author:AbrutynEE,
pubmed-author:BoucherH WHW,
pubmed-author:CampionMM,
pubmed-author:CoreyG RGR,
pubmed-author:CosgroveS ESE,
pubmed-author:FowlerV GVG,
pubmed-author:KanafaniZ AZA,
pubmed-author:KarchmerA WAW,
pubmed-author:LalaniTT,
pubmed-author:LevineD PDP,
pubmed-author:PriceC SCS,
pubmed-author:RehmS JSJ,
pubmed-author:S. aureus Endocarditis and Bacteraemia Study Group,
pubmed-author:ViglianiG AGA
|
pubmed:issnType |
Electronic
|
pubmed:volume |
61
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
177-82
|
pubmed:meshHeading |
pubmed-meshheading:17999973-Adult,
pubmed-meshheading:17999973-Aged,
pubmed-meshheading:17999973-Aged, 80 and over,
pubmed-meshheading:17999973-Anti-Bacterial Agents,
pubmed-meshheading:17999973-Daptomycin,
pubmed-meshheading:17999973-Drug Administration Schedule,
pubmed-meshheading:17999973-Female,
pubmed-meshheading:17999973-Humans,
pubmed-meshheading:17999973-Injections, Intravenous,
pubmed-meshheading:17999973-Male,
pubmed-meshheading:17999973-Middle Aged,
pubmed-meshheading:17999973-Osteoarthritis,
pubmed-meshheading:17999973-Staphylococcal Infections,
pubmed-meshheading:17999973-Staphylococcus aureus,
pubmed-meshheading:17999973-Treatment Outcome
|
pubmed:year |
2008
|
pubmed:articleTitle |
Outcomes with daptomycin versus standard therapy for osteoarticular infections associated with Staphylococcus aureus bacteraemia.
|
pubmed:affiliation |
Division of Infectious Diseases, Duke Clinical Research Institute, Durham, NC, USA. lalan002@mc.duke.edu
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|